rfhg_165074.1

Basic information about the TSS

---

TSS ID: rfhg_165074.1 TSS ID(Version3): hg_139195.1 hg_139197.1 hg_139198.1 hg_139196.1 Species: human Chr: chr14		Start: 34982943 End: 34983150 Strand: +
Source datasets	FANTOM5|PRJNA548673|PRJDB5282|PRJNA401781|PRJNA4843412 |DRA013844|PRJNA597322|PRJNA615891
Protocol	CAGE|ReCappable-seq|C1CAGE|RAMPAGE|NETCAGE|oligo_capping |STRIPE-seq|SLIC_CAGE|TIF-seq2
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2708365,EH38E1708276)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000677561.1:0 ENST00000679045.1:0 ENST00000553923.2:0 ENST00000678477.1:0 ENST00000677621.1:0 ENST00000553544.1:0 ENST00000678519.1:0 ENST00000678627.1:0 ENST00000555317.5:0 ENST00000216774.11:0 ENST00000555557.5:0 ENST00000678274.1:0 ENST00000556380.3:0 AK312853:0 AK293319:0 AK300824:0 BC003389:0 BC000652:0 GeneID: 6729 HGNC/MGI_ID: HGNC:11301 UniProt_ID: B4DDS7 G3V3L9 G3V4F7 P61011 Nearer transcript ids and distances: U51920:27 ENST00000678963.1:-242 ENST00000555746.6:-252 ENST00000554803.5:-261 ENST00000546080.6:-261 ENST00000678836.1:-306 view more...

Gene_name: signal recognition particle 54 Gene_symbol: SRP54 Gene_synonyms: Gene_source: HGNC:11301

TATA-Box annotation

---

Distance to TSS:	54
Nearest PromoterID:	NM_003136
Entrez ID:	6729
Nearest Unigene:	Hs.167535
Nearest Refseq:	NM_003136
Nearest Ensembl:	ENSG00000100883
Gene Name:	signal recognition particle 54
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.053140
GC%:	0.552885
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SRP54 p2@SRP54 p3@SRP54 p4@SRP54 p5@SRP54
Sample		p1@SRP54	p2@SRP54	p3@SRP54	p4@SRP54	p5@SRP54
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	40.13	28.05	3.70	5.84	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	39.25	25.49	2.83	7.08	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	41.09	32.99	3.47	5.79	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	36.38	31.60	3.53	4.99	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	30.82	25.42	3.60	6.30	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	30.43	35.85	2.91	6.01	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	59.48	29.85	3.70	4.58	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	49.17	23.98	2.91	6.06	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	39.75	22.87	3.85	3.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	46.95	30.14	4.64	6.38	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	43.66	36.79	1.62	7.28	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	46.35	39.44	0.81	3.25	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	24.02	0.48	1.93	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	25.26	0.15	2.10	0.75	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	31.62	0.66	1.76	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.39	1.01	1.01	0.75	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.59	0.87	1.53	0.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	18.98	0.00	4.22	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.99	0.53	1.60	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	23.17	0.45	2.26	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.79	0.27	1.74	0.80	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	27.27	0.00	2.07	2.42	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	26.89	1.16	2.84	0.90	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.91	0.24	1.46	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.57	0.77	1.55	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	23.11	0.32	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	0.00	2.20	0.55	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	26.17	0.47	3.30	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	26.49	0.81	2.42	1.13	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	25.52	0.54	1.27	0.90	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.66	0.21	2.51	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	23.06	0.39	2.93	1.95	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	29.33	0.63	1.69	2.11	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.91	1.48	3.63	2.47	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.24	0.19	1.87	1.31	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	24.72	0.77	1.92	1.72	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	26.37	0.20	1.84	1.84	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.99	0.00	1.81	1.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	32.95	0.81	3.51	1.35	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	35.53	0.00	2.16	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.11	0.71	2.59	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.36	0.29	3.81	2.05	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.21	0.63	2.11	1.69	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	33.04	0.17	2.97	0.87	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.95	0.00	2.21	2.21	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	33.04	0.00	2.09	1.63	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.31	0.96	1.44	1.44	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	36.66	0.30	2.98	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	32.55	0.24	2.63	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	30.33	0.20	3.03	1.62	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	29.92	0.61	2.66	2.87	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.14	0.44	3.34	1.78	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	489.73	13.99	27.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.07	0.71	1.42	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	36.12	0.33	5.30	3.31	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	197.15	1.68	19.30	14.26	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	67.05	0.00	4.59	5.51	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	40.51	1.30	3.24	2.59	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.54	0.00	2.89	2.57	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	74.81	0.31	7.54	3.77	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	36.66	0.71	2.12	7.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.09	0.00	3.93	2.80	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	85.19	0.80	11.15	6.37	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	52.66	0.68	4.42	2.72	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.57	0.32	1.95	2.27	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	38.34	0.35	2.48	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	323.28	0.00	16.16	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	505.44	0.00	31.59	23.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	45.83	0.00	2.93	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	42.15	0.50	5.45	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	41.28	0.00	3.28	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	56.96	0.00	3.31	1.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	51.97	0.00	2.78	3.09	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	40.97	0.00	3.36	0.61	0.61
Adipocyte - breast, donor1	11376-118A8	50.52	1.74	2.85	2.06	1.27
Adipocyte - breast, donor2	11327-117E4	37.06	0.96	2.73	1.12	1.93
Adipocyte - omental, donor1	11473-119C6	43.00	1.78	1.65	1.27	1.15
Adipocyte - omental, donor2	11474-119C7	32.89	0.75	4.48	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	31.82	0.67	0.67	0.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	40.83	2.55	3.83	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	42.00	1.81	2.26	1.35	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	17.20	0.17	0.52	0.35	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	54.56	1.17	1.17	0.78	1.96
Adipocyte differentiation, day04, donor2	13022-139D7	34.75	0.26	1.80	1.03	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	30.66	1.67	1.12	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	28.21	0.59	1.76	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	48.42	0.64	1.61	0.48	1.53
Adipocyte differentiation, day08, donor2	13023-139D8	25.82	0.00	0.97	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	25.06	0.00	1.07	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	23.93	1.11	0.00	0.00	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	34.10	1.66	0.42	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	25.37	0.50	0.75	0.00	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	21.27	0.00	0.33	0.33	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	24.97	0.61	0.61	0.30	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	13.26	0.00	0.44	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	0.00	0.00	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.87	0.72	0.36	0.54	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	0.41	1.03	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	45.54	0.80	2.86	0.92	0.69
Anulus Pulposus Cell, donor2	11463-119B5	31.84	0.49	0.24	1.96	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	48.97	1.35	1.35	4.49	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	46.02	0.00	3.04	2.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	38.52	4.28	0.00	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	53.51	1.20	3.89	3.29	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	64.50	0.00	5.06	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	29.04	0.66	2.64	1.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	38.99	2.27	0.32	3.25	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	41.26	1.46	1.46	0.97	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	32.66	0.00	4.16	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	45.20	1.88	1.88	1.88	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	43.54	0.73	1.45	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	1.25	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	44.15	1.65	1.81	1.48	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	51.86	0.00	1.36	8.19	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	43.28	1.36	1.81	2.56	1.36
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	44.47	0.00	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	44.21	0.76	2.65	2.08	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	39.56	1.34	2.14	1.60	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	49.75	0.00	2.93	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	42.63	1.00	4.15	2.32	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	0.00	2.40	1.20	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	0.00	7.08	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	40.82	2.23	2.57	2.06	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	44.17	0.97	3.88	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	52.36	1.14	4.17	3.04	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	1.21	4.85	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	56.43	1.14	2.85	3.42	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	39.76	1.71	2.57	2.35	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.00	1.29	2.06	2.06	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	40.82	1.41	1.41	3.75	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	37.30	1.61	2.89	2.57	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.96	2.14	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	36.85	1.75	2.34	2.34	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	46.37	1.81	1.51	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	1.19	1.19	3.56	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	50.35	1.53	2.03	3.56	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	36.42	1.02	4.58	1.78	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	26.05	0.64	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.02	2.16	1.73	0.86	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	45.09	2.33	2.96	2.54	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.97	0.58	0.87	1.16	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	52.91	1.89	0.94	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	45.43	1.02	1.86	1.70	1.53
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	2.11	2.11	0.00	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	40.31	1.07	1.29	1.72	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	29.48	0.00	0.60	2.41	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	51.76	2.92	2.92	0.73	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.92	0.92	3.68	2.53	1.84
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	0.00	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	50.34	1.27	3.31	4.07	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	45.00	1.24	3.72	4.54	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.41	0.92	2.14	2.14	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	61.19	0.00	2.87	2.39	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	43.68	1.77	4.21	1.33	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	1.53	9.15	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	40.43	0.55	3.32	3.88	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	53.49	1.85	4.50	1.85	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	29.80	0.00	2.54	3.27	0.36
Astrocyte - cerebellum, donor1	11500-119F6	20.76	1.47	0.37	0.37	0.49
Astrocyte - cerebellum, donor2	11580-120F5	12.15	0.34	0.51	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	5.66	0.84	0.63	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	61.70	1.74	3.83	0.70	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	43.84	2.43	2.75	1.94	1.13
Astrocyte - cerebral cortex, donor3	11392-118C6	57.73	1.64	3.88	0.75	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	123.75	11.81	6.08	4.13	3.33
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	114.26	11.90	10.02	4.89	2.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	115.05	11.27	8.31	5.01	2.73
Basophils, donor1	12241-129G9	22.49	2.35	0.26	3.92	0.26
Basophils, donor2	12242-129H1	44.74	2.53	2.53	6.49	1.80
Basophils, donor3	12243-129H2	24.70	3.38	2.50	3.09	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	6.25	0.43	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	5.03	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	0.00	0.00	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	10.81	0.83	0.21	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.96	1.38	0.46	0.69	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	40.85	0.72	1.62	0.72	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.12	21.95	2.78	1.44	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	97.59	8.38	14.91	6.06	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	33.26	2.88	3.84	2.88	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	23.67	5.64	1.13	4.51	2.25
CD14+ Monocytes, donor2	11305-117B9	24.13	6.50	1.48	5.38	0.19
CD14+ Monocytes, donor3	11381-118B4	24.59	8.56	3.07	5.71	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	68.21	4.53	1.98	0.57	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	57.62	2.65	1.90	3.03	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	74.95	0.99	3.29	2.96	1.31
CD14+ monocytes - mock treated, donor1	11863-125A9	51.31	8.67	1.59	4.05	1.30
CD14+ monocytes - mock treated, donor2	11873-125C1	33.19	3.92	2.72	2.41	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	36.96	7.58	2.37	4.26	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	37.66	7.03	2.01	2.18	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	36.43	5.24	0.83	4.14	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	58.76	12.15	2.23	10.17	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	55.22	9.20	2.94	3.52	1.96
CD14+ monocytes - treated with BCG, donor2	11870-125B7	48.79	6.59	3.56	4.63	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	79.00	16.32	3.92	12.84	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	59.23	17.09	2.34	3.51	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	60.72	16.37	3.17	8.98	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	72.11	29.95	2.22	15.53	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	36.44	8.78	2.68	3.57	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	38.91	4.39	1.80	3.39	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	55.80	13.12	2.91	9.37	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	59.71	11.90	2.29	5.49	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	46.15	9.05	2.26	7.92	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	52.38	6.11	5.67	7.42	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	51.38	9.95	2.69	4.57	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	62.46	7.68	2.62	5.06	1.57
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	58.49	10.52	1.68	8.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	58.79	10.47	2.39	2.39	2.02
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	39.45	5.28	1.41	2.82	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	50.01	8.34	2.63	3.51	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	54.23	10.46	3.31	4.36	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	47.20	7.43	2.97	7.06	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	74.58	17.46	4.96	12.72	1.94
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	51.19	12.28	1.64	3.69	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	66.53	8.11	2.55	7.19	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	70.06	15.08	3.02	14.85	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	35.96	3.49	1.09	1.96	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	36.50	2.08	3.23	3.00	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	39.42	4.55	1.08	3.90	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	46.09	6.70	0.78	3.27	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	43.84	4.19	0.87	1.75	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	64.22	5.35	1.56	3.57	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	38.28	0.26	0.77	1.79	2.04
CD14-CD16+ Monocytes, donor2	11800-124C9	39.30	1.10	0.88	2.20	1.98
CD14-CD16+ Monocytes, donor3	11911-125G3	56.43	2.11	0.84	2.32	1.68
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	6.10	0.00	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	74.58	4.75	4.07	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	66.28	3.11	0.00	2.07	5.18
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	87.95	12.79	2.13	3.73	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	77.73	6.43	1.61	0.00	2.14
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	75.81	9.83	0.70	0.70	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	64.32	5.49	2.35	2.35	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	75.14	13.18	3.95	0.00	3.95
CD19+ B Cells, donor1	11544-120B5	29.59	24.66	3.29	5.75	3.29
CD19+ B Cells, donor2	11624-122B4	24.66	12.33	2.90	4.35	2.18
CD19+ B Cells, donor3	11705-123B4	33.82	10.10	2.52	6.06	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	130.91	9.70	16.97	11.31	5.25
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	90.68	7.99	8.79	11.19	2.80
CD34+ Progenitors, donor1	11545-120B6	15.06	1.00	1.00	11.04	1.00
CD34+ Progenitors, donor2	11625-122B5	38.20	5.06	3.37	12.36	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	46.59	3.01	4.88	5.26	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	53.44	2.25	5.64	5.86	2.03
CD4+ T Cells, donor1	11225-116C1	45.70	6.43	2.86	9.64	0.71
CD4+ T Cells, donor2	11306-117C1	40.42	6.74	4.29	6.74	1.22
CD4+ T Cells, donor3	11382-118B5	38.12	8.84	5.18	19.21	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	91.12	3.06	0.77	0.51	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	84.90	2.70	1.57	0.22	3.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	66.12	1.72	0.86	1.15	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	66.37	6.16	4.74	5.69	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	69.53	7.73	3.51	3.51	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	3.30	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	89.02	2.02	1.73	0.43	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	65.92	4.41	1.19	0.34	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	59.97	3.06	1.45	0.97	2.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	63.66	6.28	2.24	5.38	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	58.35	3.84	0.70	1.75	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	73.92	3.08	1.32	3.52	3.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	68.31	3.79	0.84	2.11	3.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	59.84	1.25	1.25	0.62	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.78	2.00	0.33	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	66.90	9.52	3.81	5.71	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	81.46	5.36	2.14	3.75	6.43
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	62.76	3.59	1.79	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	106.99	3.34	2.60	1.67	3.34
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	74.73	2.82	1.73	0.65	2.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	74.60	3.57	1.47	1.05	3.57
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	63.20	6.57	5.56	5.06	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	62.82	3.47	4.33	6.50	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	87.60	6.54	3.92	5.67	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	80.17	1.48	1.48	0.49	3.46
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	66.47	2.77	0.92	0.92	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	92.12	1.40	2.79	1.40	6.98
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	111.60	3.05	1.94	1.66	3.05
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	144.29	2.21	1.72	1.96	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	75.46	4.62	3.08	0.00	3.08
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	92.39	2.51	1.43	0.72	3.58
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	2.77	1.38	1.38	4.15
CD8+ T Cells, donor1	11226-116C2	57.95	6.88	9.49	19.64	0.98
CD8+ T Cells, donor2	11307-117C2	40.55	7.13	3.00	14.64	0.75
CD8+ T Cells, donor3	11383-118B6	45.95	7.32	6.31	16.16	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	33.03	4.59	4.13	4.36	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	33.31	3.35	5.99	7.19	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	4.10	6.02	4.92	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	57.94	5.40	7.81	9.61	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.92	1.92	6.00	6.24	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.74	3.64	3.64	5.46	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	30.20	8.47	4.78	5.21	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.79	3.16	5.00	6.58	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.13	4.46	4.46	8.21	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.73	4.53	4.83	6.94	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.83	4.65	4.07	6.10	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.37	4.26	2.13	6.93	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	25.39	2.63	3.50	27.58	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.50	4.10	4.10	26.41	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	31.33	2.98	2.24	23.87	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	28.81	1.80	2.16	6.48	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	42.01	3.74	3.74	6.04	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	28.52	2.36	2.59	5.42	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	38.98	5.70	6.02	7.29	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.76	5.23	5.23	7.07	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	30.46	3.85	6.09	8.34	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.95	7.27	3.44	9.94	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.83	3.55	3.94	4.34	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	34.04	2.27	3.78	3.78	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.84	11.24	5.62	48.18	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	54.56	8.39	1.40	55.25	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	60.11	18.03	4.01	43.08	1.00
Cardiac Myocyte, donor1	11525-119I4	18.28	0.00	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	34.59	0.99	2.96	6.42	0.00
Cardiac Myocyte, donor3	11686-122I3	50.30	1.58	4.21	7.16	0.74
Chondrocyte - de diff, donor1	11261-116G1	72.11	1.04	1.04	2.08	1.04
Chondrocyte - de diff, donor2	11338-117F6	26.65	1.42	0.71	0.71	1.78
Chondrocyte - de diff, donor3	11410-118E6	31.86	1.25	1.25	0.46	1.02
Chondrocyte - re diff, donor2	11339-117F7	80.57	0.90	2.69	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	48.93	0.81	1.62	1.62	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	69.08	3.67	3.79	1.15	1.38
Ciliary Epithelial Cells, donor2	11323-117D9	52.16	2.57	5.34	1.28	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	50.89	2.04	3.45	2.74	0.97
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.79	4.31	3.48	2.38	3.58
Corneal Epithelial Cells, donor1	11526-119I5	5.05	0.00	0.00	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	9.10	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	11.76	0.51	0.77	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	47.05	1.65	2.48	3.14	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	50.15	0.32	1.89	2.52	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.96	0.86	3.24	2.81	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.01	3.07	3.76	4.44	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	25.46	1.96	1.96	3.26	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	30.97	2.90	2.90	5.32	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	25.85	0.67	1.83	2.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	21.12	0.59	2.35	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	20.93	0.85	0.57	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	9.83	0.39	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	18.91	0.58	2.62	3.20	0.29
Endothelial Cells - Artery, donor2	11341-117F9	34.82	0.24	1.65	1.65	0.47
Endothelial Cells - Artery, donor3	11413-118E9	29.80	1.05	2.28	2.45	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	52.53	0.89	2.44	1.33	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	72.72	1.52	2.43	3.35	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	63.99	0.28	3.10	1.41	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	27.34	0.30	0.89	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	22.39	0.00	1.56	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	11.77	0.57	1.42	0.71	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	81.62	2.00	2.40	5.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	20.44	1.57	1.05	1.57	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	83.87	1.49	4.35	3.85	0.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.46	0.87	2.17	1.30	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	45.80	1.34	2.32	1.34	0.61
Endothelial Cells - Vein, donor1	11267-116G7	11.38	0.00	2.28	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	16.07	0.70	0.00	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	28.26	0.47	2.20	2.04	0.00
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	143.57	18.15	33.01	130.37	4.95
Eosinophils, donor3	12246-129H5	124.84	21.40	32.10	85.60	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	0.24	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	47.21	1.64	2.46	1.64	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.26	1.97	1.09	1.64	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.85	0.65	0.43	0.54	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	49.60	2.55	2.79	1.94	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	124.19	5.60	5.73	6.69	4.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.49	1.48	2.11	0.84	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	75.09	3.43	3.43	3.16	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.19	1.99	3.65	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	31.30	1.81	4.54	3.18	0.00
Fibroblast - Cardiac, donor2	11345-117G4	32.59	1.52	2.27	6.06	0.76
Fibroblast - Cardiac, donor3	11417-118F4	29.34	1.10	2.68	1.73	0.32
Fibroblast - Cardiac, donor4	11452-119A3	61.83	2.73	5.76	2.12	1.82
Fibroblast - Cardiac, donor5	11456-119A7	61.04	1.27	2.92	3.05	0.25
Fibroblast - Cardiac, donor6	11460-119B2	48.81	1.97	2.88	2.27	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	29.88	0.80	0.67	0.40	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	34.08	2.59	2.59	2.59	1.29
Fibroblast - Choroid Plexus, donor3	11653-122E6	58.59	1.46	2.93	1.46	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	19.37	1.15	0.00	0.23	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	38.67	1.70	2.04	0.85	1.36
Fibroblast - Dermal, donor1	11269-116G9	31.93	1.88	2.35	0.70	0.70
Fibroblast - Dermal, donor2	11346-117G5	26.89	0.00	0.00	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	34.45	1.09	1.57	0.24	1.33
Fibroblast - Dermal, donor4	11450-119A1	61.50	1.47	1.24	1.13	0.79
Fibroblast - Dermal, donor5	11454-119A5	54.25	2.44	1.74	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	71.30	0.81	4.71	1.62	0.65
Fibroblast - Gingival, donor1	11237-116D4	63.51	3.12	1.25	0.21	1.46
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.80	1.31	2.88	1.57	1.05
Fibroblast - Gingival, donor2	11318-117D4	50.87	2.11	2.77	0.13	1.05
Fibroblast - Gingival, donor3	11394-118C8	43.70	1.45	1.06	0.39	1.55
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	45.71	1.04	3.12	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.20	1.59	1.41	0.18	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	49.11	3.59	3.59	0.78	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	45.71	2.16	2.57	1.22	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.23	0.35	0.35	0.71	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	52.06	1.46	3.66	1.75	2.05
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	52.50	3.27	4.09	0.55	2.73
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.12	1.97	3.95	1.54	1.43
Fibroblast - Gingival, donor9 (control)	11927-125I1	39.18	0.44	1.76	0.29	0.88
Fibroblast - Lung, donor1	11270-116H1	10.87	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	37.30	2.98	2.98	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	38.62	1.06	2.11	0.84	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	19.89	0.41	0.41	0.81	0.81
Fibroblast - Mammary, donor2	11620-122A9	11.98	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	64.21	1.36	2.33	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	81.76	0.76	3.49	1.37	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	93.63	0.92	4.90	1.22	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	1.53	2.29	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	44.82	1.62	2.43	0.81	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.07	0.70	1.51	0.46	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	60.57	0.88	6.96	9.40	0.99
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	25.60	0.61	0.41	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	14.03	0.00	0.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	31.63	0.79	1.98	1.19	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	102.60	4.56	1.79	2.38	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	43.87	1.07	1.24	0.89	3.20
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.42	1.77	3.74	1.18	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	81.23	6.02	2.71	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	74.92	2.37	1.51	1.08	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	114.14	2.28	5.06	2.28	1.52
Fibroblast - skin normal, donor1	11553-120C5	42.99	2.63	1.80	1.15	1.64
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	125.92	3.41	7.22	2.61	2.81
Fibroblast - skin normal, donor2	11561-120D4	85.49	1.81	2.41	2.71	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	149.00	2.42	6.35	3.02	3.93
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	48.30	1.82	1.74	0.91	2.07
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	63.08	1.54	1.37	0.17	1.71
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	96.89	3.28	3.94	2.63	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	81.28	2.02	2.98	2.77	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	45.71	4.05	1.52	1.18	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	45.01	0.94	3.61	1.25	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	842.07	22.16	44.32	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	30.50	3.49	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	53.22	2.77	2.08	2.43	1.39
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	65.32	2.08	4.68	3.90	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	56.47	3.07	3.58	2.30	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	31.39	6.89	3.83	6.89	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	35.09	8.93	11.49	13.40	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	74.74	13.12	8.56	9.70	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	54.60	5.52	5.79	2.21	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.70	6.39	4.34	3.65	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	53.50	7.13	5.75	6.14	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	55.25	6.34	7.67	2.91	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.21	9.46	2.94	5.87	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	63.68	8.84	7.96	12.38	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	37.45	10.18	5.94	3.82	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	51.23	7.39	5.79	2.09	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	36.26	8.06	6.72	3.76	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	40.27	4.21	6.44	2.11	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	37.51	4.01	6.09	4.15	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	34.15	4.07	6.71	2.24	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	36.74	6.39	3.88	2.28	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	36.75	4.24	5.73	2.49	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	38.25	5.03	3.28	1.31	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.00	3.84	3.84	1.48	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.49	6.04	3.81	2.38	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	32.17	6.93	3.57	4.02	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.47	5.04	4.44	1.61	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	41.05	6.79	5.09	3.05	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	51.78	11.88	5.76	3.72	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	56.50	7.60	4.58	2.08	1.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	50.72	8.88	3.59	2.22	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	40.06	8.08	4.43	1.99	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	52.41	8.07	5.32	3.08	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.95	11.23	5.10	3.06	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	37.75	4.95	2.06	1.86	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	39.66	6.46	5.42	2.54	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	35.69	6.50	3.84	1.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	30.86	5.29	3.09	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.56	6.40	5.29	1.48	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.63	5.35	3.57	0.65	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	44.26	6.74	4.17	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	34.96	6.06	2.84	1.04	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	30.53	6.17	4.11	1.11	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	43.79	6.39	3.34	1.22	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.98	5.33	3.76	1.57	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	32.27	4.61	4.17	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	39.84	6.45	2.52	1.40	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.20	4.91	4.17	1.20	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	35.83	5.08	5.08	1.87	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	41.31	6.27	3.83	1.38	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	40.55	6.61	4.02	1.42	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	43.10	6.23	4.07	1.08	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.90	4.42	4.24	1.84	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	33.55	4.82	2.63	1.10	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	50.58	1.98	4.96	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.46	3.96	1.71	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.89	1.61	2.42	1.61	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	55.41	3.30	3.56	1.52	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	70.67	16.32	5.97	7.56	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	36.82	9.86	4.31	3.08	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	41.12	16.37	5.93	6.34	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	35.05	9.70	5.95	6.57	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	42.67	10.17	6.50	7.06	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	47.50	6.00	6.00	6.92	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	14.85	9.90	9.90	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	53.77	9.28	10.44	10.44	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	9.63	3.21	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	6.96	3.48	6.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	58.91	13.02	7.81	6.18	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	53.12	10.30	12.77	10.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	63.31	0.00	10.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	8.11	9.23	8.11	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	55.56	10.13	8.50	6.21	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	43.62	8.39	4.19	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	49.94	8.59	6.04	5.41	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.97	6.45	7.13	7.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	6.26	16.71	8.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	58.42	5.73	7.45	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	39.66	5.03	4.44	4.14	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	5.08	11.86	10.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	59.65	10.36	11.60	9.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	51.09	9.90	9.90	6.44	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	15.81	5.27	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	36.52	6.54	7.69	5.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	44.33	7.17	9.45	4.89	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	40.13	6.69	3.34	4.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	60.10	5.01	7.71	3.85	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	69.49	19.51	10.95	11.30	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	2.48	14.91	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	61.34	6.13	7.55	4.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	60.95	4.83	6.03	4.83	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	51.88	9.66	8.14	5.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.85	9.17	8.38	5.58	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	78.44	6.91	5.43	8.39	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	57.84	4.72	14.17	12.98	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	56.59	7.00	4.67	7.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	82.95	8.34	6.58	6.58	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	51.71	6.78	5.09	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.83	3.58	5.97	5.37	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	41.25	7.76	4.37	7.28	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	1.14	4.57	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	35.34	0.83	1.25	0.42	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	20.24	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	39.01	0.95	0.63	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	28.82	1.25	0.84	0.84	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	60.34	2.55	2.44	10.44	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	58.74	5.57	4.05	13.17	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	57.33	5.23	2.73	11.15	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.39	4.70	3.72	8.74	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	57.81	7.52	2.79	8.60	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	52.31	5.60	3.01	10.55	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	54.42	4.11	4.48	9.84	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	55.58	5.15	3.09	8.75	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	52.54	3.84	3.20	12.17	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	6.92	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	0.00	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	10.23	1.06	0.35	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	9.44	0.00	1.45	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.91	1.92	5.59	6.47	1.05
Hepatocyte, donor1	11523-119I2	113.80	8.47	8.47	3.63	14.53
Hepatocyte, donor2	11603-120I1	61.41	3.23	3.23	5.39	2.15
Hepatocyte, donor3	11684-122I1	84.05	4.29	4.29	2.45	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.90	7.18	1.96	5.22	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	108.54	15.03	6.82	6.99	2.80
Iris Pigment Epithelial Cells, donor1	11530-119I9	59.68	1.10	5.21	3.29	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	31.84	0.00	6.37	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	6.68	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	4.15	1.38	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	5.01	5.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	2.56	0.00	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	8.12	1.62	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	11.67	3.33	5.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	3.63	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	2.65	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	4.43	4.43	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	2.52	3.15	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	7.73	9.28	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.86	3.88	3.23	3.88	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	1.61	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	23.63	7.33	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.27	1.68	2.10	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	21.70	1.61	3.21	1.61	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	14.77	1.85	1.85	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	1.42	2.36	1.89	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	0.91	1.81	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	12.91	1.08	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	19.06	1.27	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	16.43	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	1.28	3.19	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	10.94	3.65	0.00	3.65	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	17.85	4.28	2.14	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.52	1.23	1.85	0.93	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	1.76	1.76	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	3.14	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.86	0.70	0.00	3.48	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	4.43	0.00	4.43	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	6.48	0.00	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	8.72	0.00	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	12.80	0.00	2.13	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	1.39	1.39	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	16.57	1.84	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	15.86	0.00	1.06	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	32.31	1.06	1.22	2.12	0.90
Keratinocyte - epidermal, donor2	11349-117G8	13.47	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	47.42	1.51	3.03	2.46	0.66
Keratinocyte - oral, donor1	11251-116E9	66.29	3.63	1.70	1.25	1.14
Keratocytes, donor1	11527-119I6	20.63	1.72	2.06	0.69	0.00
Keratocytes, donor2	11607-120I5	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	30.83	0.79	0.79	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	35.17	4.40	0.00	0.00	6.59
Lens Epithelial Cells, donor1	11529-119I8	52.86	1.08	1.08	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	50.63	4.15	1.50	0.81	1.04
Lens Epithelial Cells, donor3	11690-122I7	45.51	2.12	2.42	1.21	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.58	2.49	2.13	1.19	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.07	1.95	0.84	0.84	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	47.07	2.20	2.36	2.83	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.97	0.54	1.61	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	10.72	0.32	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	16.50	0.65	0.54	1.19	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.96	2.87	2.87	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	0.00	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	19.42	1.41	1.13	1.27	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.57	1.19	1.98	1.19	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	20.94	1.74	1.74	1.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.37	0.37	0.00	0.37	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.18	2.44	1.39	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	16.46	1.67	1.43	0.95	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	14.28	1.37	0.41	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.64	2.46	1.23	1.54	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	11.22	0.94	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	18.67	0.37	0.73	1.46	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.71	1.97	0.00	1.97	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.08	2.05	1.17	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	0.50	0.75	1.49	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	2.42	0.97	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.66	1.35	1.35	1.89	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	21.04	1.21	1.82	2.12	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	20.22	0.52	1.56	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.59	2.30	0.84	2.09	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.50	0.90	1.65	1.65	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.20	2.06	1.38	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	16.56	1.88	0.56	1.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.41	0.21	0.74	0.74	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	2.91	0.97	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.55	1.65	1.32	1.65	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.39	0.62	0.50	0.87	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	38.50	3.33	2.59	1.85	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.26	0.99	2.22	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	12.10	1.10	0.96	0.82	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	23.48	1.93	2.25	1.61	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.69	2.13	3.35	2.43	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	35.41	1.54	2.52	2.94	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.11	2.13	2.13	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.24	1.94	1.94	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.78	0.00	0.62	0.62	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	24.35	1.79	2.51	1.43	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	15.03	1.96	0.33	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.12	0.47	0.47	1.41	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	31.19	1.61	2.10	2.35	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	8.71	0.51	1.02	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.02	1.79	0.90	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	23.78	6.14	0.00	0.77	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	27.46	8.16	2.97	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	26.23	11.42	2.12	2.54	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	20.40	7.03	2.81	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	6.54	0.93	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	20.61	8.24	0.52	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	15.46	7.14	1.19	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	28.73	7.46	1.36	2.49	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	28.79	8.72	1.45	2.62	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	39.62	11.25	2.70	3.60	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	35.50	8.94	2.30	3.66	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	28.24	10.78	2.05	2.05	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	31.76	9.53	2.82	1.06	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	19.99	11.99	0.67	2.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	27.00	12.23	1.53	2.55	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	42.16	13.61	1.87	3.20	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.01	10.58	3.59	3.21	1.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.09	7.98	1.23	1.84	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	16.31	7.34	0.00	3.26	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	39.57	7.50	1.87	2.29	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	28.31	12.89	1.40	3.92	1.40
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	26.79	14.42	2.06	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	36.87	9.29	2.03	2.32	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	30.19	10.16	0.90	4.48	1.20
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	32.64	13.83	1.66	1.66	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	25.45	6.36	1.41	1.06	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	7.74	1.48	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	19.57	4.61	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	23.41	9.21	0.38	1.92	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	18.68	7.93	0.00	3.40	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	31.18	9.03	0.00	3.28	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	25.31	9.04	1.36	2.26	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	20.83	8.62	0.72	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	32.12	8.96	1.49	1.49	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.67	6.32	1.11	2.60	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	33.17	11.63	0.86	3.02	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	31.68	6.85	3.43	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	25.99	5.33	1.00	2.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	25.94	10.86	1.81	3.62	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	1.42	1.42	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	26.81	8.25	2.06	2.41	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	7.51	0.00	3.76	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	10.10	2.02	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.56	7.04	0.74	3.33	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	36.05	10.47	1.16	4.65	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	14.81	6.35	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	24.81	6.80	1.20	2.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	10.18	0.00	2.18	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	33.73	11.50	0.00	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	28.61	7.40	2.96	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	11.29	2.82	1.88	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	34.19	10.56	3.52	1.01	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	24.78	9.91	3.15	5.41	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	18.93	13.77	1.72	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.51	10.24	0.89	0.89	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	30.50	10.56	2.74	3.13	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	21.11	14.51	0.66	0.00	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	33.73	8.30	3.11	3.11	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	32.38	9.19	3.06	3.94	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	35.22	11.74	1.12	0.56	2.80
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	28.71	8.83	0.88	1.77	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	23.91	8.87	1.93	1.54	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	20.76	8.10	0.51	2.53	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.91	8.17	0.96	3.84	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.07	7.55	1.99	3.18	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	16.41	6.08	0.61	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	7.61	2.77	3.46	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	30.02	4.18	2.66	3.80	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.82	5.68	0.52	3.61	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	28.42	5.44	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	28.52	7.29	1.58	0.95	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	26.12	3.20	0.53	5.33	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	26.43	5.75	4.02	2.30	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	25.71	7.20	2.57	3.09	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.88	5.66	1.41	2.83	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	30.64	9.65	0.00	2.27	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	24.13	2.91	1.66	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.79	9.40	0.78	3.92	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	34.24	6.68	1.67	1.67	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	26.48	7.90	0.93	2.32	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	24.09	7.36	2.01	3.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	30.47	5.88	3.74	4.81	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	28.29	4.45	1.21	3.23	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	20.19	8.26	1.84	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	27.56	0.89	1.78	4.45	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	27.35	3.99	2.85	3.42	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	4.60	2.30	2.30	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	33.92	3.83	2.74	2.19	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	23.61	3.12	2.23	4.01	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.15	3.64	1.56	2.08	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	32.49	5.30	1.33	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	10.39	4.16	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	46.04	1.37	2.05	0.68	1.60
Macrophage - monocyte derived, donor2	11313-117C8	51.38	0.92	5.32	5.32	1.47
Macrophage - monocyte derived, donor3	11389-118C3	39.59	0.39	2.36	2.88	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	42.48	4.78	4.25	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	74.31	2.85	3.33	3.49	1.43
Mallassez-derived cells, donor3	11930-125I4	73.52	3.75	5.28	5.98	1.25
Mammary Epithelial Cell, donor1	11273-116H4	76.43	3.99	2.89	1.69	1.49
Mammary Epithelial Cell, donor2	11350-117G9	61.09	5.21	1.16	3.19	1.45
Mammary Epithelial Cell, donor3	11422-118F9	18.21	0.75	1.00	0.50	0.75
Mast cell - stimulated, donor1	11487-119E2	254.23	0.68	61.01	115.25	6.78
Mast cell, donor1	11563-120D6	60.99	0.65	3.46	3.14	1.62
Mast cell, donor2	11565-120D8	66.57	2.38	4.75	10.10	3.27
Mast cell, donor3	11566-120D9	72.94	3.60	2.93	5.85	2.25
Mast cell, donor4	11567-120E1	75.70	3.01	4.79	9.75	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	82.62	1.77	3.66	2.44	2.88
Mast cell, expanded and stimulated, donor8	11942-126A7	77.05	2.92	10.51	18.68	2.33
Mast cell, expanded, donor5	11939-126A4	48.99	0.69	1.95	1.26	1.38
Mast cell, expanded, donor8	11941-126A6	42.68	2.68	2.34	4.52	0.67
Melanocyte - dark, donor1	11502-119F8	45.07	1.69	2.98	1.59	0.80
Melanocyte - dark, donor2	11582-120F7	39.11	0.35	4.50	4.50	0.35
Melanocyte - dark, donor3	11663-122F7	75.92	1.45	4.35	1.59	0.72
Melanocyte - light, donor1	11274-116H5	18.34	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	10.24	0.68	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	13.88	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	39.67	1.46	2.50	0.73	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	41.42	0.54	5.38	2.15	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	38.04	2.41	4.55	1.07	0.54
Meningeal Cells, donor1	11493-119E8	38.58	1.12	0.99	1.12	0.25
Meningeal Cells, donor2	11573-120E7	32.13	0.44	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	71.64	3.75	4.89	2.53	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	67.58	0.86	2.85	1.14	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.88	2.31	4.73	4.43	0.91
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	11.77	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	51.67	1.44	5.02	3.59	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	41.93	3.18	2.96	2.12	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	34.18	3.02	3.02	1.51	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	23.95	0.44	0.44	1.10	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.15	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.71	0.61	0.82	0.82	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	82.69	1.11	2.77	1.52	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	11.52	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	57.63	1.97	2.37	1.97	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	18.10	0.00	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	0.64	1.28	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	71.24	2.13	3.90	2.84	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	55.04	1.88	3.13	2.19	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	45.72	5.81	2.90	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	45.34	1.86	5.04	7.42	1.06
Mesothelial Cells, donor2	12156-128G5	37.03	0.50	4.00	5.51	1.50
Mesothelial Cells, donor3	11402-118D7	32.66	1.01	5.13	4.55	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	21.61	0.00	4.05	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	35.96	1.72	6.90	6.40	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.21	1.77	4.42	7.95	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.06	1.86	5.89	3.10	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	26.14	0.62	3.11	8.50	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	36.29	1.00	5.51	5.51	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	32.12	1.40	3.72	6.52	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.53	0.61	5.89	5.89	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.97	1.98	4.36	4.36	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.01	3.54	0.00	5.31	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	29.64	0.76	4.18	11.40	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	0.00	2.63	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	31.62	2.12	3.61	6.58	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	0.00	0.00	4.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	25.93	0.60	4.17	8.35	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	0.00	0.00	1.68	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	32.37	2.01	5.52	7.03	1.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	26.86	1.19	4.52	12.60	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	0.55	0.55	2.21	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	34.31	2.76	4.14	8.52	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.14	1.26	6.31	7.15	1.68
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.85	1.83	6.32	7.95	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	32.61	3.00	5.58	9.87	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	27.56	0.44	3.78	14.23	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.76	1.75	5.26	9.42	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.18	0.51	2.53	5.58	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	1.66	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.97	1.36	5.71	11.69	1.90
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.00	1.47	5.88	15.00	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	4.36	0.00	2.18	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	29.79	0.48	6.25	10.09	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	40.02	2.80	11.21	26.01	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	0.00	0.00	2.74	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	43.05	3.00	7.51	7.51	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	26.95	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	0.00	8.15	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	52.11	5.26	6.57	16.20	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	0.00	1.10	9.93	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.01	0.00	2.56	5.12	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	61.73	3.97	10.66	24.79	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	26.44	0.70	9.74	13.22	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	4.42	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	51.97	3.08	8.55	20.17	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.44	0.44	4.81	19.26	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.01	0.00	2.13	5.68	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	49.10	2.81	10.10	20.76	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.26	0.00	9.14	26.60	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.73	0.58	2.91	5.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.47	1.21	6.33	18.40	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	57.60	2.09	12.52	34.64	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	2.77	10.16	7.39	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	35.29	3.41	13.66	29.03	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	30.95	0.55	6.49	9.40	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	45.09	1.81	9.85	18.92	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	30.89	2.14	7.72	32.60	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	0.00	1.27	2.54	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	36.03	1.60	5.87	13.61	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	39.21	1.50	3.29	12.27	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.99	0.99	4.66	5.51	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	46.82	2.23	8.28	12.74	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.53	1.77	8.62	28.75	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	0.00	3.03	4.93	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	48.30	3.98	11.93	18.18	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	52.85	2.21	7.87	20.65	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	0.65	1.30	2.61	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	37.64	0.59	4.12	9.70	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	46.71	2.02	5.77	8.07	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	49.05	0.41	2.47	4.95	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	35.73	1.79	3.87	2.68	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	23.17	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	29.90	1.97	0.99	1.64	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	22.09	0.00	1.05	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	32.82	2.37	1.38	2.17	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	34.46	0.93	1.86	1.86	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	34.17	1.50	2.63	2.63	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	22.91	0.80	4.26	1.60	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	39.81	1.81	1.13	1.36	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	13.26	1.47	0.74	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.92	2.20	1.10	1.47	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	42.00	3.11	4.67	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.96	6.95	0.53	0.53	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	0.00	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	29.29	1.01	2.02	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	28.25	0.42	2.11	2.95	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	47.67	10.90	4.09	27.24	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	22.25	12.08	3.81	3.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	46.16	21.06	4.05	13.77	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	21.15	1.51	24.17	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	79.94	5.71	119.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	81.56	3.26	114.19	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	0.00	9.50	71.29	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	62.75	0.00	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	66.79	1.51	4.31	5.60	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	40.24	2.09	0.52	1.05	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	17.35	0.67	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	17.11	0.42	2.09	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	50.20	1.90	3.42	0.38	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	46.28	1.60	6.38	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.88	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	145.17	0.00	11.03	1.84	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	12.56	2.09	0.84	2.09	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	27.20	1.16	1.86	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	15.67	0.00	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	37.21	1.68	2.73	1.89	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	289.50	11.13	0.00	0.00	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.32	0.99	1.99	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.98	0.81	1.62	0.27	1.89
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	17.23	2.04	0.91	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.37	0.65	1.14	0.16	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.26	1.64	2.92	1.09	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	21.75	1.06	1.06	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	12.61	0.00	2.40	1.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	50.21	0.98	3.28	0.66	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	13.99	0.81	0.49	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.04	1.23	2.47	1.41	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	2.11	1.41	2.11	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	17.47	1.84	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.21	1.61	1.93	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	51.39	1.72	5.52	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	166.88	0.00	7.59	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	29.18	1.78	1.56	0.67	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	18.21	0.00	3.39	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.50	0.00	0.24	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.04	0.86	2.15	0.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	325.00	0.00	54.17	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	16.66	0.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	36.07	0.90	1.35	2.25	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.41	0.79	0.79	2.78	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	19.50	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	0.38	0.76	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.60	0.65	0.65	0.33	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.09	0.00	4.98	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	25.58	0.88	0.00	2.65	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	1.33	1.33	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.32	0.50	0.99	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	16.84	0.77	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	38.11	1.21	1.21	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	43.54	1.33	3.32	2.21	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	173.72	5.11	10.22	0.00	15.33
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	0.61	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.53	0.31	2.52	0.31	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	14.22	0.61	0.91	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.99	0.79	1.58	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	52.15	0.00	6.80	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	268.07	0.00	10.12	0.00	15.17
Myoblast, donor1	11241-116D8	75.41	2.36	6.21	5.71	2.36
Myoblast, donor2	11322-117D8	57.92	1.73	3.64	2.11	2.11
Myoblast, donor3	11398-118D3	62.05	2.69	3.53	0.84	1.51
NK T cell leukemia cell line:KHYG-1	10777-110G3	57.21	4.38	1.61	0.58	1.02
Natural Killer Cells, donor1	11230-116C6	59.35	9.23	7.38	16.91	0.92
Natural Killer Cells, donor2	11311-117C6	37.39	12.06	3.92	9.65	1.21
Natural Killer Cells, donor3	11387-118C1	38.65	13.25	8.83	13.44	2.76
Neural stem cells, donor1	11275-116H6	83.11	7.98	10.16	2.18	2.18
Neural stem cells, donor2	11352-117H2	88.58	5.78	0.00	1.93	0.00
Neurons, donor1	11494-119E9	52.34	6.83	5.69	1.14	0.00
Neurons, donor2	11574-120E8	48.22	3.30	1.98	1.10	1.98
Neurons, donor3	11655-122E8	54.26	6.58	5.76	0.00	0.82
Neutrophils, donor1	11233-116C9	85.38	4.64	16.70	18.56	2.78
Neutrophils, donor2	11314-117C9	26.09	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	87.35	5.50	13.44	28.10	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	55.69	1.54	2.85	0.83	1.42
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	1.30	1.63	0.00	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	37.10	1.40	0.80	0.20	0.40
Olfactory epithelial cells, donor1	11933-125I7	28.49	1.10	2.89	1.51	1.10
Olfactory epithelial cells, donor2	11934-125I8	36.77	3.18	3.33	1.88	1.01
Olfactory epithelial cells, donor3	11935-125I9	34.05	1.48	2.04	1.25	1.02
Olfactory epithelial cells, donor4	11936-126A1	36.43	1.36	2.82	1.07	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	75.83	3.01	5.42	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	27.01	0.85	1.28	1.28	1.28
Osteoblast - differentiated, donor2	11353-117H3	9.14	2.29	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	25.45	1.24	0.62	0.62	0.62
Osteoblast, donor1	11277-116H8	17.59	0.98	2.74	0.59	0.00
Osteoblast, donor2	11354-117H4	92.71	4.21	7.73	4.92	0.00
Osteoblast, donor3	11426-118G4	26.30	1.24	3.73	1.60	0.18
Pancreatic stromal cells, donor1	11249-116E7	64.27	2.27	3.03	1.10	1.18
Pericytes, donor1	11491-119E6	9.57	0.56	0.33	0.22	0.11
Pericytes, donor2	11571-120E5	7.70	0.23	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	13.43	0.41	0.41	0.41	0.00
Perineurial Cells, donor1	11499-119F5	86.24	1.58	4.75	2.15	0.79
Perineurial Cells, donor2	11579-120F4	61.56	1.29	8.00	7.91	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	51.32	5.10	2.23	5.74	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.67	5.39	1.22	4.41	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.62	2.59	2.07	6.21	0.52
Placental Epithelial Cells, donor1	11278-116H9	27.03	2.15	1.20	1.20	0.72
Placental Epithelial Cells, donor2	11355-117H5	13.31	0.00	0.00	1.11	1.11
Placental Epithelial Cells, donor3	11427-118G5	15.90	1.18	0.98	0.79	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.57	0.95	1.58	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	37.33	1.31	2.44	1.50	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	106.77	1.70	6.79	4.05	1.96
Preadipocyte - breast, donor2	11328-117E5	38.73	0.90	3.15	2.03	1.13
Preadipocyte - omental, donor1	11468-119C1	38.15	1.92	1.17	1.70	1.07
Preadipocyte - omental, donor2	11329-117E6	38.41	1.75	3.06	1.31	2.18
Preadipocyte - omental, donor3	11403-118D8	46.84	1.15	3.29	1.86	1.00
Preadipocyte - perirenal, donor1	11469-119C2	17.72	0.98	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	22.42	0.31	2.46	2.46	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	66.58	1.95	4.25	1.59	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	54.32	0.85	4.94	2.55	0.51
Preadipocyte - visceral, donor1	11280-116I2	81.88	3.07	5.50	3.82	1.02
Preadipocyte - visceral, donor2	11357-117H7	63.97	1.38	2.30	4.60	2.76
Preadipocyte - visceral, donor3	11429-118G7	59.77	1.25	3.55	2.09	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	65.77	16.90	3.02	4.37	1.81
Prostate Epithelial Cells, donor2	11331-117E8	37.37	0.95	1.22	1.62	0.41
Prostate Epithelial Cells, donor3	11404-118D9	38.03	1.65	0.24	0.12	1.53
Prostate Stromal Cells, donor1	11254-116F3	49.09	1.82	3.08	2.62	0.80
Prostate Stromal Cells, donor2	11332-117E9	50.92	1.08	3.77	1.26	1.79
Prostate Stromal Cells, donor3	11405-118E1	32.22	1.46	2.82	0.94	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	12.41	0.36	0.73	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	56.70	3.26	2.63	1.32	0.97
Renal Epithelial Cells, donor1	11517-119H5	10.14	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	1.42	0.71	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	63.31	2.86	3.49	1.16	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	14.55	0.54	0.40	0.40	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	41.74	3.33	2.66	1.78	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	14.31	1.32	0.88	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	10.03	0.00	2.51	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	5.83	0.55	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.06	1.34	0.27	0.81	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.54	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	10.99	0.77	1.54	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	52.37	2.07	1.81	0.78	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.80	0.85	0.00	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	32.37	3.76	0.25	0.50	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	63.34	3.88	2.27	0.94	3.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	5.36	0.89	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	153.00	9.91	4.95	5.50	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	102.67	4.06	7.54	3.48	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	117.54	8.45	3.38	2.34	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	66.14	5.06	2.78	1.09	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	95.92	7.47	3.90	1.23	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	134.34	7.69	5.95	2.36	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	72.37	6.18	4.31	1.75	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	82.98	6.24	5.32	3.47	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	75.98	6.30	2.74	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	65.96	4.08	3.78	0.76	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	71.32	4.84	2.33	1.79	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	78.04	7.60	3.44	1.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	63.53	4.83	3.22	1.82	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	81.43	4.87	2.88	0.89	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	65.19	6.69	2.68	2.68	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	66.05	6.43	3.63	0.93	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	105.98	10.33	3.95	2.82	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	61.05	8.10	2.26	0.66	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	74.08	4.38	3.50	1.07	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	79.82	7.45	3.63	0.95	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	77.00	7.16	2.35	1.50	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	56.90	5.89	2.52	1.12	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	73.14	5.81	2.73	1.88	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	62.90	7.29	2.37	1.09	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	63.65	6.25	3.56	0.61	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	71.73	6.04	3.63	0.94	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	88.22	12.74	2.36	2.36	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	65.28	4.56	3.37	0.60	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	79.74	7.72	3.27	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	80.04	8.09	4.15	1.24	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	69.02	5.97	2.65	0.88	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	76.87	8.77	5.43	1.67	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	81.69	9.42	2.69	1.08	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	61.31	4.26	3.58	1.36	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	75.58	6.56	3.47	1.74	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	98.35	8.94	4.81	1.72	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	70.64	5.35	4.94	1.92	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	75.68	7.22	4.60	1.31	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	73.29	5.45	2.56	1.70	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	81.67	4.73	6.81	1.18	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	62.37	4.80	3.47	1.07	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	66.09	3.32	2.49	1.11	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	72.14	4.29	4.52	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	73.36	5.24	4.03	2.22	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	75.25	5.93	2.83	1.04	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	70.92	3.14	4.54	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	59.54	4.53	7.25	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	85.79	4.53	3.18	1.47	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	155.60	10.19	6.40	3.35	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	77.27	6.08	1.83	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	82.58	7.84	1.51	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	72.38	5.88	5.20	1.36	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	82.37	4.79	3.00	1.50	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	104.02	7.79	1.65	1.53	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	68.94	3.63	3.63	1.28	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	68.51	3.61	4.21	2.40	0.60
Schwann Cells, donor1	11498-119F4	13.54	0.19	0.19	0.38	0.19
Schwann Cells, donor2	11578-120F3	40.83	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.71	1.53	3.72	1.10	0.66
Sebocyte, donor1	11220-116B5	32.32	1.10	1.10	0.00	2.19
Sebocyte, donor2	11301-117B5	19.30	0.46	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	14.63	0.21	0.41	0.41	0.21
Sertoli Cells, donor1	11255-116F4	66.26	1.66	14.91	6.63	1.66
Sertoli Cells, donor2	11333-117F1	36.72	0.00	5.65	8.47	0.00
Skeletal Muscle Cells, donor1	11281-116I3	34.22	2.64	0.53	0.35	1.23
Skeletal Muscle Cells, donor2	11358-117H8	13.01	0.72	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	28.43	0.84	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	69.28	1.10	3.61	2.20	0.31
Skeletal Muscle Cells, donor5	11455-119A6	61.69	1.64	3.57	1.49	0.59
Skeletal Muscle Cells, donor6	11459-119B1	68.02	1.23	3.69	1.69	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	87.83	1.26	5.54	2.39	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	65.64	0.71	3.42	2.43	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	57.34	2.08	3.47	1.69	1.49
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	43.47	1.18	2.19	0.93	1.94
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	7.96	2.90	1.45	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	16.79	0.28	1.51	2.06	0.00
Skin - palm, donor1	10286-104F7	42.98	0.00	0.00	0.00	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	15.57	0.86	0.29	1.01	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	85.06	4.91	2.45	9.81	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.85	1.04	0.91	1.04	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	45.87	3.20	1.53	1.67	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	31.93	0.70	1.13	1.55	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	115.45	4.86	4.44	9.73	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	39.95	0.75	0.52	0.22	1.42
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	40.12	1.54	1.23	2.78	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	99.38	2.67	2.89	4.67	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	37.62	0.00	4.11	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	26.08	0.88	2.65	1.99	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.75	1.18	2.76	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	1.55	3.09	1.55	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	4.00	1.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	41.52	0.27	1.86	1.46	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	72.48	0.66	6.87	5.10	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	49.29	1.15	2.69	5.25	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	68.37	2.28	4.88	2.60	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	72.95	1.77	3.84	2.07	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	44.28	0.71	5.55	3.99	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.51	0.16	0.33	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.22	2.13	0.61	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	32.08	0.76	0.76	2.02	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.81	0.95	0.48	1.91	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	69.76	1.33	6.19	3.39	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	51.44	3.01	4.09	2.58	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	55.73	1.78	4.72	1.15	1.36
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.90	2.01	2.01	3.71	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	0.00	3.23	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	26.30	0.60	1.79	1.49	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	14.34	0.34	0.68	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	61.17	0.86	5.10	2.43	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	97.92	2.42	2.21	1.91	5.23
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	73.73	1.37	6.60	11.83	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	23.55	0.00	1.21	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	101.20	5.03	7.42	6.09	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	69.78	2.93	2.40	1.20	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	53.59	0.50	5.38	3.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	27.65	1.52	1.52	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	54.58	1.06	4.07	3.92	1.06
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	0.75	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	31.01	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	42.32	0.93	2.79	1.86	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.94	1.51	1.51	10.10	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	46.70	0.63	4.70	5.95	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.44	0.29	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	90.30	1.50	6.33	3.08	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	33.17	0.47	2.80	1.87	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.83	0.43	2.16	2.16	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	22.95	1.02	0.76	0.51	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	18.43	0.19	0.94	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	91.95	1.68	4.47	3.91	1.82
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	62.17	0.92	3.60	2.77	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.00	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.07	0.24	1.22	1.71	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	81.53	2.65	4.86	8.62	1.77
Smooth Muscle Cells - Uterine, donor3	11466-119B8	50.62	1.17	2.63	0.88	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	29.74	0.78	1.17	0.00	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	38.87	1.85	2.64	2.38	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	45.75	1.49	1.49	0.37	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	53.90	1.80	3.59	1.80	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.36	1.99	3.69	1.42	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	48.05	3.54	1.58	1.58	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	44.95	1.02	1.78	1.52	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	39.93	0.80	1.20	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	24.66	0.84	1.67	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	28.88	0.92	1.83	0.00	1.38
Synoviocyte, donor1	11291-117A4	60.43	0.84	4.54	4.71	1.51
Synoviocyte, donor2	11368-117I9	30.68	2.68	2.85	0.67	1.01
Synoviocyte, donor3	11440-118H9	27.70	0.45	0.67	0.67	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	0.71	1.07	1.07	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.11	0.93	0.23	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	27.17	1.15	1.08	0.93	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	11.98	0.77	1.55	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	2.29	0.00	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.02	4.43	1.35	1.35	1.97
Urethra, donor2	10319-105A4	17.98	0.00	0.00	0.00	8.99
Urothelial Cells, donor1	11520-119H8	6.11	0.27	0.00	0.00	0.53
Urothelial Cells, donor2	11600-120H7	10.01	0.00	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	4.81	0.23	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	68.65	0.22	3.34	1.78	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	92.54	0.89	0.89	1.78	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	92.92	2.86	2.86	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.23	2.74	0.00	2.05	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	59.91	2.07	0.69	0.00	4.13
Whole blood (ribopure), donor090325, donation2	12177-128I8	57.52	2.32	0.58	1.16	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	71.85	6.25	0.00	4.16	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	89.03	8.26	0.00	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	41.08	0.00	1.83	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	38.86	7.15	5.06	3.21	0.49
Wilms' tumor cell line:HFWT	10597-108E3	11.44	0.88	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	47.20	4.75	1.96	3.35	1.40
achilles tendon, donor2	10292-104G4	33.06	0.00	2.07	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	77.76	10.45	2.80	2.04	3.57
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	88.69	9.75	6.50	6.27	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	78.82	13.18	3.32	1.90	1.90
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	97.96	15.78	7.62	7.89	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	70.27	3.09	4.50	2.81	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	59.64	4.02	3.60	4.23	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	48.18	7.08	6.53	6.53	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.22	2.20	7.49	9.69	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	44.10	3.27	3.68	4.08	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	51.64	5.82	3.49	1.16	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	40.48	7.36	1.10	1.29	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	15.60	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	50.66	1.63	6.74	6.97	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	71.97	4.40	1.81	6.99	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	62.83	3.51	2.63	2.34	1.46
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	36.25	2.79	2.32	2.79	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.47	6.58	3.29	1.65	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	17.19	6.75	1.23	1.23	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	56.33	7.68	1.28	4.27	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.49	5.76	3.34	3.34	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	45.25	7.70	2.17	4.81	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	50.56	3.34	0.89	1.11	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	38.36	3.34	3.34	4.67	3.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	5.57	11.15	13.01	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	62.15	7.53	6.03	4.14	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	49.72	5.23	3.93	3.93	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	20.62	1.87	5.62	5.62	1.87
adenocarcinoma cell line:IM95m	10796-110I4	39.56	6.83	0.71	0.71	0.47
adipose tissue, adult, pool1	10010-101C1	41.26	1.24	1.40	0.78	1.09
adipose, donor1	10184-103D4	136.05	5.86	18.18	9.97	0.59
adipose, donor2	10185-103D5	49.88	1.62	3.65	3.24	0.00
adipose, donor3	10186-103D6	47.65	6.81	4.08	3.00	0.27
adipose, donor4	10187-103D7	73.67	10.40	8.67	6.07	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	31.09	5.05	1.10	0.79	1.42
adrenal gland, adult, pool1	10081-102A9	29.10	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	70.71	3.20	1.33	1.47	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.37	8.58	2.14	0.36	1.43
amniotic membrane cells, donor1	12235-129G3	42.43	2.55	0.70	3.48	3.25
amniotic membrane cells, donor2	12236-129G4	69.65	4.06	1.35	1.69	4.06
amniotic membrane cells, donor3	12237-129G5	53.03	3.24	0.59	2.06	3.24
amygdala - adult, donor10196	10167-103B5	59.29	5.93	5.93	4.74	4.74
amygdala, adult, donor10252	10151-102I7	46.43	3.45	1.82	0.20	3.04
amygdala, newborn, donor10223	10360-105E9	36.80	4.20	3.87	5.49	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	112.69	6.88	2.42	1.91	3.31
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.54	5.74	4.19	1.10	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	32.40	17.04	7.01	11.02	0.33
aorta, adult, pool1	10052-101G7	42.36	1.18	2.55	1.18	1.57
appendix, adult	10189-103D9	45.41	3.88	0.78	1.94	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	72.23	11.35	6.88	2.06	0.69
artery, adult	10190-103E1	36.68	4.08	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	97.64	6.52	9.27	5.36	1.30
b cell line:RPMI1788	10427-106D4	119.41	5.20	4.16	3.57	2.83
basal cell carcinoma cell line:TE 354.T	10702-109G9	64.65	2.22	1.39	1.66	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	34.33	5.95	1.59	1.39	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	74.48	19.58	0.33	0.00	3.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.11	2.80	1.68	1.68	0.00
bladder, adult, pool1	10011-101C2	53.02	2.06	0.65	0.43	3.69
blood, adult, pool1	10053-101G8	22.15	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	1.71	1.71	0.00	0.00
bone marrow, adult	10192-103E3	51.29	2.02	0.67	2.02	2.02
brain, adult, donor1	10084-102B3	28.70	0.00	3.08	0.00	3.08
brain, adult, pool1	10012-101C3	58.46	3.45	2.00	0.67	3.79
brain, fetal, pool1	10085-102B4	37.40	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	38.98	4.63	2.97	1.32	4.29
breast carcinoma cell line:MDA-MB-453	10419-106C5	125.32	6.49	1.62	1.62	6.24
breast, adult, donor1	10080-102A8	28.41	3.16	0.63	1.26	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	66.06	5.72	1.14	1.40	1.40
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	76.38	10.51	2.78	2.16	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	115.80	2.07	8.98	6.91	3.68
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	45.27	2.66	1.21	1.21	1.94
carcinoid cell line:NCI-H1770	10703-109H1	98.27	7.05	3.29	4.70	0.47
carcinoid cell line:NCI-H727	10735-110B6	67.38	3.61	1.53	1.09	3.50
carcinoid cell line:SK-PN-DW	10719-109I8	48.17	7.29	4.12	1.27	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	54.83	10.11	2.93	1.33	1.06
caudate nucleus - adult, donor10196	10177-103C6	52.96	2.30	6.91	1.15	4.61
caudate nucleus, adult, donor10252	10164-103B2	43.17	1.67	3.85	0.50	3.68
caudate nucleus, adult, donor10258	10379-105H1	38.21	1.53	3.06	2.29	2.29
caudate nucleus, newborn, donor10223	10354-105E3	45.05	3.30	2.93	6.59	2.20
cerebellum - adult, donor10196	10173-103C2	119.44	17.48	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	73.02	8.97	0.21	0.21	5.12
cerebellum, adult, pool1	10083-102B2	39.32	2.41	2.07	0.34	3.10
cerebellum, newborn, donor10223	10357-105E6	58.95	9.96	0.83	3.32	2.49
cerebral meninges, adult	10188-103D8	39.84	2.02	2.52	0.25	2.52
cerebrospinal fluid, donor2	10294-104G6	21.20	1.46	0.73	0.00	2.92
cervical cancer cell line:D98-AH2	10552-107I3	63.70	5.61	0.58	0.58	4.74
cervical cancer cell line:ME-180	10553-107I4	97.11	6.79	2.65	3.81	0.17
cervix, adult, pool1	10013-101C4	59.00	3.04	1.57	0.52	5.14
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	56.85	6.41	1.67	1.67	2.65
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	1.31	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	80.78	5.97	1.99	1.86	1.24
choriocarcinoma cell line:SCH	10785-110H2	82.55	21.81	4.19	6.04	2.22
choriocarcinoma cell line:T3M-3	10618-108G6	37.71	1.66	0.95	0.71	1.66
chorionic membrane cells, donor1	12238-129G6	37.32	1.99	0.85	1.14	2.28
chorionic membrane cells, donor2	12239-129G7	77.06	1.89	6.16	2.39	0.30
chorionic membrane cells, donor3	12240-129G8	63.19	2.20	1.10	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	46.45	9.09	2.02	5.05	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	47.26	1.92	2.11	2.50	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	37.59	1.48	5.07	7.18	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	38.52	5.65	1.80	4.11	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	47.41	5.81	3.63	6.53	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	46.83	6.31	7.53	4.07	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	48.29	5.01	8.83	5.59	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	81.05	12.51	10.43	6.78	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	59.89	5.49	2.51	2.74	1.37
clear cell carcinoma cell line:TEN	10636-108I6	88.66	14.23	1.74	3.12	2.78
colon carcinoma cell line:CACO-2	10513-107D9	70.84	21.42	8.24	11.17	1.83
colon carcinoma cell line:COLO-320	10420-106C6	111.36	10.64	7.60	2.66	3.04
colon, adult, donor1	10082-102B1	28.56	2.38	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	42.77	2.70	1.18	0.82	2.00
colon, fetal, donor1	10070-101I7	35.84	3.09	2.47	0.62	1.85
common myeloid progenitor CMP, donor1	12130-128D6	45.84	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	116.43	31.87	8.92	12.75	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	67.77	8.90	7.55	10.11	2.41
cord blood derived cell line:COBL-a untreated	10449-106F8	83.48	9.02	10.72	10.43	1.27
corpus callosum, adult, pool1	10042-101F6	77.61	3.10	1.88	0.44	4.64
cruciate ligament, donor2	10295-104G7	32.42	0.00	0.00	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	38.52	2.41	1.61	0.00	0.80
diencephalon, adult	10193-103E4	38.16	2.64	1.92	1.20	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.09	11.25	2.98	2.30	4.13
ductal cell carcinoma cell line:KLM-1	10438-106E6	82.57	8.98	0.51	2.82	5.39
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	43.57	4.33	8.67	4.09	0.72
ductus deferens, adult	10196-103E7	80.23	1.99	2.49	1.50	3.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	48.97	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	58.12	0.00	2.21	1.47	1.47
dura mater, adult, donor1	10041-101F5	65.41	1.82	7.27	5.04	2.73
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	54.85	45.30	2.89	6.66	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	57.89	17.34	4.44	2.29	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	24.05	1.85	1.23	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	33.30	3.94	0.91	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	30.26	3.70	3.09	1.23	1.54
embryonic pancreas cell line:2C6	10603-108E9	27.58	6.57	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	54.30	2.35	9.72	6.03	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	70.86	5.98	2.72	1.99	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	44.71	4.02	3.22	3.70	1.61
epidermoid carcinoma cell line:A431	10426-106D3	80.37	4.89	3.22	9.78	1.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	96.79	11.00	3.96	3.96	2.53
epididymis, adult	10197-103E8	50.86	2.51	1.88	0.84	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.95	5.14	4.97	2.13	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	20.45	5.51	1.97	1.18	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	62.77	15.46	3.41	3.15	1.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	54.62	11.42	2.07	1.67	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	58.37	9.52	3.02	4.26	0.90
esophagus, adult, pool1	10015-101C6	44.06	1.70	0.32	0.42	2.76
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	83.41	17.28	10.65	5.39	2.50
eye - muscle inferior rectus, donor1	10272-104E2	33.80	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	23.15	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	32.74	0.00	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	37.83	1.15	0.00	2.29	3.44
eye - vitreous humor, donor1	10268-104D7	29.15	5.83	4.37	4.37	0.00
eye, fetal, donor1	10054-101G9	49.07	3.81	1.78	0.25	3.31
fibrosarcoma cell line:HT-1080	10758-110E2	46.80	3.33	1.41	1.92	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	57.93	3.56	1.66	2.61	0.71
frontal lobe, adult, pool1	10040-101F4	77.31	2.44	3.38	0.94	4.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	116.80	21.32	6.31	2.10	4.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	112.74	8.14	1.19	1.01	5.03
gall bladder, adult	10198-103E9	36.21	0.24	2.17	0.24	2.66
gamma delta positive T cells, donor1	11937-126A2	63.89	3.22	4.29	1.61	2.68
gamma delta positive T cells, donor2	11938-126A3	59.76	2.61	3.36	0.75	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.53	5.70	1.69	1.90	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	41.20	7.54	0.97	0.58	2.51
gastric cancer cell line:AZ521	10549-107H9	70.17	12.79	6.39	7.38	0.33
gastric cancer cell line:GSS	10560-108A2	28.37	1.83	0.92	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	102.35	6.40	6.63	5.94	2.06
giant cell carcinoma cell line:LU65	10487-107B1	50.14	12.39	0.80	0.69	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	48.85	4.20	2.66	1.26	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	47.64	1.00	0.75	0.25	1.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	25.44	1.48	0.95	1.16	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	29.49	1.54	0.70	0.56	1.54
glioblastoma cell line:T98G	10485-107A8	35.65	4.53	2.32	1.32	0.88
glioma cell line:GI-1	10413-106B8	31.92	1.76	2.93	1.46	0.59
globus pallidus - adult, donor10196	10175-103C4	43.01	3.64	1.46	2.92	3.64
globus pallidus, adult, donor10252	10161-103A8	75.67	5.61	0.73	0.24	2.93
globus pallidus, adult, donor10258	10367-105F7	42.45	1.37	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	29.84	4.26	2.66	4.26	3.20
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	0.00	0.00	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	29.44	0.64	1.92	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	55.09	3.67	4.59	11.48	1.38
hIPS +CCl2, biol_rep2	14384-156C1	44.35	9.60	5.94	11.89	0.46
hIPS +CCl2, biol_rep3	14385-156C2	41.87	11.59	4.51	7.73	1.29
hIPS, biol_rep1	14380-156B6	21.56	30.18	7.19	18.68	1.44
hIPS, biol_rep2	14381-156B7	37.72	9.60	4.12	7.54	0.00
hIPS, biol_rep3	14382-156B8	54.07	3.31	1.10	1.10	4.41
hairy cell leukemia cell line:Mo	10712-109I1	61.49	4.88	4.02	4.60	2.30
heart - mitral valve, adult	10205-103F7	44.25	0.60	0.30	0.60	1.79
heart - pulmonic valve, adult	10206-103F8	46.28	0.52	0.52	1.05	2.09
heart - tricuspid valve, adult	10207-103F9	32.47	1.67	0.00	2.50	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	42.04	4.08	1.43	0.00	1.84
heart, adult, diseased, donor1	10051-101G6	25.98	0.43	0.00	0.43	1.70
heart, adult, pool1	10016-101C7	23.00	0.46	0.46	0.46	0.46
heart, fetal, pool1	10046-101G1	68.69	3.70	2.57	1.95	2.77
hepatic mesenchymal tumor cell line:LI90	10778-110G4	54.30	0.31	3.39	1.23	0.93
hepatoblastoma cell line:HuH-6	10633-108I3	35.68	7.14	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	147.73	26.96	26.96	16.91	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	156.94	29.62	24.52	18.08	2.06
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	160.37	33.04	26.78	20.21	2.43
hepatoma cell line:Li-7	10484-107A7	43.04	8.01	3.45	2.22	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	51.15	9.85	4.12	2.01	1.61
hippocampus - adult, donor10196	10169-103B7	52.05	4.73	3.79	0.95	3.79
hippocampus, adult, donor10252	10153-102I9	46.13	3.06	0.82	0.20	3.27
hippocampus, adult, donor10258	10374-105G5	33.86	2.99	0.50	1.00	4.98
hippocampus, newborn, donor10223	10363-105F3	21.85	2.82	1.41	3.17	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	93.38	12.82	15.87	20.14	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	40.65	10.21	6.68	4.91	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.48	8.89	6.86	7.87	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.01	6.77	5.64	3.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	33.31	5.68	7.23	3.87	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.34	10.25	5.69	0.76	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	49.34	9.63	5.26	3.80	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	55.58	8.62	3.88	4.31	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.88	5.84	5.42	5.84	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	57.07	8.29	3.32	3.55	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	53.52	8.20	5.46	2.41	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.00	11.45	8.75	4.04	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	46.16	10.02	5.48	7.98	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	50.60	8.84	6.88	12.77	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	68.07	20.95	11.35	26.18	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	48.68	5.54	7.45	3.25	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	45.79	5.23	6.11	2.62	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	67.47	3.00	10.49	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	76.11	4.33	3.39	3.20	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	70.94	7.28	6.37	7.28	4.09
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	70.48	5.64	2.51	2.19	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.17	5.88	5.72	2.29	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.29	5.23	4.94	2.32	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	41.85	4.18	5.08	2.69	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	51.91	8.87	6.28	8.13	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	41.65	8.84	4.85	5.71	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.09	14.29	11.02	12.25	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	51.76	5.63	3.17	4.58	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	45.93	5.38	4.12	2.22	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	5.14	3.33	2.72	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	57.40	9.83	3.10	2.59	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	54.46	10.63	4.65	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.95	8.72	3.33	2.57	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	54.45	5.11	4.60	3.58	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	51.49	12.12	2.27	3.03	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	43.35	7.73	3.70	3.70	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	41.30	10.87	5.07	6.76	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	51.70	12.92	5.79	11.14	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	45.85	9.27	8.78	9.27	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.93	4.89	3.36	5.81	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	435.93	48.80	29.28	29.28	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	67.18	8.60	6.62	4.96	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	67.87	4.38	2.19	4.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	52.11	8.32	4.34	2.90	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	57.30	9.25	1.42	3.56	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	10.74	2.39	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	68.53	10.56	4.06	3.79	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	41.22	7.81	3.77	2.42	1.35
immature langerhans cells, donor1	11904-125F5	60.54	5.09	11.38	23.49	1.45
immature langerhans cells, donor2	11905-125F6	43.57	8.71	3.17	20.60	1.58
insula, adult, pool1	10039-101F3	56.59	3.41	2.84	0.47	2.65
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	4.23	2.28	2.28	1.30
kidney, adult, pool1	10017-101C8	79.50	5.11	4.51	2.60	2.80
kidney, fetal, pool1	10045-101F9	49.94	3.47	0.99	0.64	1.49
large cell lung carcinoma cell line:IA-LM	10509-107D5	138.75	29.11	12.92	7.53	2.27
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.45	1.38	2.21	0.97	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	57.99	3.67	1.65	1.83	1.10
left atrium, adult, donor1	10079-102A7	29.97	2.18	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	36.91	0.51	0.00	0.51	2.02
leiomyoblastoma cell line:G-402	10721-110A1	28.46	3.01	2.74	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	25.51	1.44	1.44	2.51	2.16
leiomyoma cell line:15242A	10570-108B3	50.00	1.09	1.09	8.70	0.54
leiomyoma cell line:15425	10571-108B4	35.94	1.21	1.46	1.46	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	34.50	10.46	3.14	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	72.61	3.78	9.09	12.63	0.47
liposarcoma cell line:KMLS-1	10782-110G8	35.62	0.94	3.28	1.09	0.47
liposarcoma cell line:SW 872	10726-110A6	50.56	4.75	6.09	3.90	0.73
liver, adult, pool1	10018-101C9	118.14	4.21	7.78	6.81	3.57
liver, fetal, pool1	10086-102B5	19.75	0.00	0.94	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	40.54	4.96	1.02	0.00	2.48
locus coeruleus, adult, donor10252	10165-103B3	54.07	3.69	0.74	0.37	3.32
locus coeruleus, adult, donor10258	10375-105G6	43.73	2.82	1.13	0.56	3.39
locus coeruleus, newborn, donor10223	10362-105F2	60.15	7.15	3.36	4.21	3.36
lung adenocarcinoma cell line:A549	10499-107C4	66.98	3.46	2.21	0.83	1.94
lung adenocarcinoma cell line:PC-14	10408-106B3	24.82	2.07	0.00	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	80.28	5.27	1.19	1.05	2.90
lung, adult, pool1	10019-101D1	52.57	2.72	1.65	0.83	1.54
lung, fetal, donor1	10068-101I5	155.26	6.85	2.85	4.57	5.14
lung, right lower lobe, adult, donor1	10075-102A3	38.95	2.29	1.37	0.92	0.46
lymph node, adult, donor1	10077-102A5	44.97	2.84	0.47	0.00	2.37
lymphangiectasia cell line:DS-1	10727-110A7	68.16	3.29	0.66	0.88	3.51
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	76.07	16.90	3.62	1.81	4.53
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.02	4.25	0.00	0.00	4.25
mature adipocyte, donor1	12231-129F8	31.52	0.44	0.44	0.00	1.33
mature adipocyte, donor2	12232-129F9	41.51	1.04	1.04	1.25	1.25
mature adipocyte, donor3	12233-129G1	41.96	1.42	1.19	0.71	1.66
mature adipocyte, donor4	12234-129G2	46.06	0.26	0.26	1.05	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	52.89	12.15	0.48	0.48	7.15
medial frontal gyrus - adult, donor10196	10170-103B8	57.53	2.26	2.26	1.13	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	40.28	2.76	1.84	0.37	4.41
medial frontal gyrus, adult, donor10258	10368-105F8	41.93	1.91	1.27	1.59	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	91.69	4.26	6.40	22.60	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	59.06	3.54	3.54	1.35	4.05
medial temporal gyrus, adult, donor10252	10156-103A3	45.84	2.55	0.42	0.42	3.40
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	32.75	5.78	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	430.61	0.00	43.06	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	28.00	6.10	2.87	17.23	0.36
medulla oblongata - adult, donor10196	10174-103C3	47.38	3.89	0.65	0.65	4.54
medulla oblongata, adult, donor10252	10155-103A2	49.69	3.87	1.08	0.46	1.86
medulla oblongata, adult, pool1	10038-101F2	52.81	2.69	1.06	0.98	4.16
medulla oblongata, newborn, donor10223	10361-105F1	34.02	3.12	1.04	1.04	2.43
medulloblastoma cell line:D283 Med	10838-111E1	41.18	14.39	3.99	0.66	0.89
medulloblastoma cell line:ONS-76	10759-110E3	26.17	3.30	1.96	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	53.33	5.61	2.44	0.57	2.44
melanoma cell line:G-361	10465-106H6	35.02	1.09	1.90	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	30.75	2.53	0.90	0.90	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	70.49	8.81	6.17	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	53.92	10.89	4.41	2.07	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	69.81	1.84	5.68	3.22	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	46.54	1.45	2.54	1.27	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	43.07	1.66	4.56	2.07	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.62	1.40	2.11	0.70	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	42.94	2.70	2.50	1.35	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	62.47	2.08	4.16	1.39	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	47.54	1.54	1.20	2.06	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	48.88	1.38	3.45	3.11	0.69
mesenchymal precursor cell - cardiac, donor3	11754-123G8	56.24	1.33	4.38	3.85	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	79.13	1.49	7.70	6.89	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	61.17	3.98	6.54	2.56	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	45.12	0.99	1.98	0.99	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	69.88	0.83	6.78	6.37	0.83
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	50.62	1.75	2.79	3.14	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	51.04	1.84	1.84	2.45	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	32.71	1.08	2.52	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	48.31	0.72	3.93	1.66	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	31.46	1.37	2.28	5.02	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	100.69	1.26	7.55	8.81	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	52.75	1.34	2.24	1.49	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	50.86	1.75	5.43	4.29	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.55	0.00	3.31	1.84	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	40.06	0.57	2.00	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	47.57	3.37	3.79	2.11	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	32.42	1.37	3.20	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	32.48	1.28	1.28	0.51	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	31.41	1.05	2.62	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	32.04	0.92	1.85	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.30	1.18	1.88	0.71	2.82
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.91	0.68	1.69	1.35	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	30.26	1.57	1.18	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	26.41	0.93	1.85	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	51.63	2.02	3.17	0.87	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	33.69	1.78	1.34	0.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	29.08	1.68	2.16	0.48	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	0.73	0.73	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.48	0.34	1.01	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.61	2.05	0.41	1.23	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.07	1.29	1.72	0.86	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	5.16	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	22.41	0.65	1.95	0.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	0.00	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	3.73	0.00	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	0.82	2.45	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	22.16	1.17	1.55	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	0.99	1.99	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.13	0.59	0.59	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	24.37	1.22	1.22	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	1.90	3.17	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	25.87	0.69	0.69	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	0.00	0.81	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.89	0.00	2.38	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	0.59	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.14	0.62	0.94	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	1.18	0.00	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.90	0.00	1.38	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	0.00	0.49	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	26.92	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.17	0.64	0.00	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.16	2.01	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	20.27	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.88	3.64	0.00	0.00	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	4.52	9.04	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	22.24	1.65	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.37	0.99	0.79	0.20	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	17.20	0.65	0.97	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	26.48	0.00	0.00	2.04	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	34.04	0.77	2.32	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	67.09	2.13	1.18	0.94	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	67.19	7.88	8.11	14.60	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	12.82	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	55.28	4.93	4.42	3.80	0.92
mesothelioma cell line:Mero-25	10850-111F4	35.63	5.45	4.77	9.31	0.00
mesothelioma cell line:Mero-41	10851-111F5	36.18	1.22	0.73	1.96	1.47
mesothelioma cell line:Mero-48a	10852-111F6	22.59	1.99	1.33	1.55	0.00
mesothelioma cell line:Mero-82	10853-111F7	38.90	6.83	3.42	4.47	1.05
mesothelioma cell line:Mero-83	10854-111F8	33.02	1.87	4.77	6.47	0.51
mesothelioma cell line:Mero-84	10855-111F9	26.79	1.52	2.53	4.80	1.01
mesothelioma cell line:Mero-95	10856-111G1	31.47	1.86	2.69	4.55	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	37.77	3.81	1.66	3.98	1.16
mesothelioma cell line:NCI-H226	10846-111E9	27.15	5.97	6.52	8.51	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	30.06	7.69	1.71	2.05	0.68
mesothelioma cell line:NCI-H28	10845-111E8	31.04	4.58	0.76	1.27	1.78
mesothelioma cell line:No36	10857-111G2	23.49	6.20	0.98	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	34.95	4.88	2.71	3.25	0.81
migratory langerhans cells, donor1	11901-125F2	110.55	1.54	3.65	3.84	5.18
migratory langerhans cells, donor2	11902-125F3	76.93	0.85	1.95	0.85	3.05
migratory langerhans cells, donor3	11903-125F4	98.53	1.26	4.31	2.69	3.59
mixed mullerian tumor cell line:HTMMT	10689-109F5	82.60	8.49	1.31	0.98	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	63.16	2.97	8.90	8.48	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	65.19	0.92	1.61	1.61	1.61
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.06	2.85	3.62	3.43	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	90.36	12.75	2.03	2.77	4.80
myeloma cell line:PCM6	10474-106I6	101.01	4.15	0.40	0.99	1.98
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.13	1.01	2.54	2.03	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	42.17	3.92	1.57	0.00	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	41.12	4.68	0.11	0.11	1.78
nasal epithelial cells, donor1, tech_rep2	12226-129F3	45.89	5.00	0.15	0.07	1.32
nasal epithelial cells, donor2	12227-129F4	59.61	1.10	1.66	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	63.04	12.65	3.68	1.38	0.69
neuroblastoma cell line:NB-1	10539-107G8	65.67	7.30	4.86	1.50	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	45.13	14.76	2.95	1.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	49.94	16.96	2.98	0.37	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	30.13	5.46	3.56	0.95	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.23	8.87	4.28	1.58	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	44.68	14.09	6.44	1.01	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	22.89	3.81	2.54	0.64	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	38.59	1.06	2.13	3.46	0.27
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	204.64	17.08	10.49	9.30	5.75
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	64.84	2.40	3.20	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	33.66	0.96	2.24	1.60	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	48.35	1.31	3.42	2.10	0.79
nucleus accumbens, adult, pool1	10037-101F1	61.21	2.06	3.37	1.03	3.19
occipital cortex - adult, donor10196	10172-103C1	61.81	4.12	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	53.67	5.90	1.61	0.81	2.95
occipital cortex, newborn, donor10223	10355-105E4	25.48	4.37	1.46	13.83	1.82
occipital lobe, adult, donor1	10076-102A4	48.81	1.57	2.36	0.26	2.62
occipital lobe, fetal, donor1	10073-102A1	49.78	4.72	3.43	1.29	2.15
occipital pole, adult, pool1	10036-101E9	34.06	1.58	0.95	0.55	2.44
olfactory region, adult	10195-103E6	41.84	1.53	0.76	0.57	3.06
optic nerve, donor1	10277-104E7	68.04	0.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	41.35	13.78	1.59	1.03	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	57.56	14.15	4.40	4.40	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	63.84	6.60	4.23	5.25	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.32	5.54	1.27	1.73	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	42.63	0.29	1.76	1.47	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	54.19	0.93	7.47	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	59.38	2.33	5.94	2.12	2.54
ovary, adult, pool1	10020-101D2	46.91	2.27	2.10	1.05	2.71
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	70.58	3.12	6.23	5.50	1.10
pancreas, adult, donor1	10049-101G4	102.53	0.00	0.94	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	35.78	5.31	1.96	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	37.31	5.45	1.19	0.85	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	86.43	4.47	1.82	6.79	2.98
paracentral gyrus, adult, pool1	10035-101E8	56.29	1.92	1.83	0.64	3.48
parietal cortex, adult, donor10258	10373-105G4	57.99	2.20	0.73	0.00	5.14
parietal lobe - adult, donor10196	10171-103B9	64.89	6.58	0.94	0.94	9.40
parietal lobe, adult, donor10252	10157-103A4	44.75	4.28	0.29	0.00	2.57
parietal lobe, adult, pool1	10034-101E7	53.40	2.73	1.76	1.06	4.32
parietal lobe, fetal, donor1	10072-101I9	64.01	11.64	1.94	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	30.66	4.86	2.62	17.95	0.75
parotid gland, adult	10199-103F1	130.73	0.62	1.85	3.08	4.32
penis, adult	10200-103F2	35.45	1.07	2.15	0.00	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	26.03	5.02	0.37	1.12	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.20	5.39	2.48	1.17	2.62
pineal gland - adult, donor10196	10179-103C8	64.50	3.87	0.65	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	130.29	11.25	1.78	0.59	3.55
pineal gland, adult, donor10258	10377-105G8	63.33	5.02	1.88	0.63	3.14
pituitary gland - adult, donor10196	10180-103C9	145.70	2.02	3.04	0.00	5.06
pituitary gland, adult, donor10252	10162-103A9	231.40	10.42	1.04	0.52	10.94
pituitary gland, adult, donor10258	10378-105G9	116.62	5.96	0.85	3.40	4.26
placenta, adult, pool1	10021-101D3	58.59	2.58	1.51	0.54	2.69
plasma cell leukemia cell line:ARH-77	10840-111E3	110.71	7.28	4.77	2.65	2.52
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.75	0.47	1.56	0.16	2.33
pons, adult, pool1	10033-101E6	73.59	3.87	1.98	0.60	6.89
postcentral gyrus, adult, pool1	10032-101E5	43.94	1.83	1.48	0.70	3.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	11.74	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	152.94	15.00	9.47	7.28	1.60
prostate cancer cell line:PC-3	10439-106E7	96.20	5.99	7.62	3.63	3.27
prostate, adult, pool1	10022-101D4	41.81	1.54	0.63	0.18	2.36
putamen, adult, donor10196	10176-103C5	55.95	3.54	5.67	2.60	3.07
putamen, adult, donor10252	10152-102I8	35.29	1.96	1.96	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	4.37	4.37	6.56	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	37.93	2.66	3.14	1.69	2.42
putamen, newborn, donor10223	10365-105F5	91.46	3.00	3.00	5.25	3.75
rectal cancer cell line:TT1TKB	10469-106I1	144.30	22.11	3.78	5.53	2.91
rectum, fetal, donor1	10067-101I4	50.08	4.17	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	53.00	3.18	0.64	0.64	4.66
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	116.81	6.21	0.83	0.41	2.90
retina, adult, pool1	10030-101E3	57.45	4.08	0.89	0.40	3.68
retinoblastoma cell line:Y79	10475-106I7	75.08	8.05	4.68	3.12	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	58.52	8.98	9.84	8.98	1.35
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	41.62	5.06	2.25	0.56	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	23.49	0.00	3.03	2.27	0.00
salivary acinar cells, donor1	11771-123I7	36.58	1.94	2.27	2.27	0.97
salivary acinar cells, donor2	11772-123I8	34.42	1.10	1.51	0.69	0.96
salivary acinar cells, donor3	11773-123I9	25.16	0.66	0.00	2.65	0.66
salivary gland, adult, pool1	10093-102C3	151.57	4.58	0.57	1.14	5.15
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	54.80	7.50	2.61	1.77	1.35
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	60.77	6.11	2.82	2.00	1.29
seminal vesicle, adult	10201-103F3	79.89	2.65	3.17	1.59	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	76.76	8.02	3.40	2.19	4.37
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.38	0.50	1.26	1.26	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	36.13	1.00	2.01	1.00	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	56.01	3.36	1.75	1.07	2.28
signet ring carcinoma cell line:Kato III	10436-106E4	67.64	5.64	1.88	2.21	1.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.22	4.13	0.90	2.58	0.90
skeletal muscle - soleus muscle, donor1	10282-104F3	40.43	2.84	0.71	0.00	2.84
skeletal muscle, adult, pool1	10023-101D5	41.86	2.04	0.48	0.24	2.40
skeletal muscle, fetal, donor1	10066-101I3	21.11	1.01	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	20.36	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	53.65	3.79	0.63	0.00	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	62.04	12.34	1.00	1.33	2.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	83.84	19.86	2.52	2.52	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.78	2.31	2.51	2.89	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	54.56	13.85	0.99	0.33	2.14
small cell lung carcinoma cell line:NCI-H82	10842-111E5	109.06	6.59	4.50	2.25	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	115.93	28.33	5.01	2.62	1.96
small intestine, adult, pool1	10024-101D6	73.46	3.34	0.84	0.84	3.94
small intestine, fetal, donor1	10064-101I1	41.77	2.95	1.23	0.49	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	68.73	4.10	0.00	0.51	3.59
smooth muscle, adult, pool1	10048-101G3	42.65	1.29	0.26	0.00	2.58
somatostatinoma cell line:QGP-1	10781-110G7	80.41	3.22	0.00	0.27	2.14
spinal cord - adult, donor10196	10181-103D1	44.28	3.21	2.52	0.92	3.67
spinal cord, adult, donor10252	10159-103A6	65.84	5.91	1.97	0.79	3.94
spinal cord, adult, donor10258	10369-105F9	74.71	9.69	0.00	0.69	6.92
spinal cord, fetal, donor1	10056-101H2	40.86	1.83	3.66	0.61	3.05
spinal cord, newborn, donor10223	10359-105E8	66.13	5.05	1.84	0.92	4.13
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	45.25	0.75	1.79	1.49	0.30
spleen, adult, pool1	10025-101D7	54.63	1.65	2.09	1.32	1.32
spleen, fetal, pool1	10044-101F8	47.20	2.07	2.62	1.75	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	54.03	7.97	2.90	2.07	1.86
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	123.61	12.15	4.18	3.42	2.66
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	76.18	12.23	2.45	2.10	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	101.64	3.91	0.78	1.95	2.35
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	275.21	43.45	7.65	4.50	13.17
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	38.55	7.20	0.85	1.69	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.08	4.23	2.54	2.96	0.42
stomach, fetal, donor1	10062-101H8	28.84	2.14	7.48	1.07	1.07
submaxillary gland, adult	10202-103F4	117.92	6.27	1.14	1.71	3.99
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	66.67	8.31	1.25	0.62	3.12
substantia nigra, adult, donor10258	10371-105G2	53.79	4.66	0.52	2.07	8.28
substantia nigra, newborn, donor10223	10358-105E7	27.56	2.83	0.00	1.41	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	68.32	3.44	7.34	3.21	0.92
temporal lobe, adult, pool1	10031-101E4	33.15	1.86	1.19	0.59	2.37
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	56.98	4.99	2.14	0.71	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	40.00	3.52	1.76	0.88	1.76
tenocyte, donor1	11763-123H8	59.70	0.70	2.09	2.09	1.40
tenocyte, donor2	11765-123I1	35.48	1.53	1.53	0.00	0.76
tenocyte, donor3	11768-123I4	50.78	1.11	2.59	1.48	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	44.53	9.69	5.78	3.40	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	85.24	9.56	8.02	5.09	0.62
teratocarcinoma cell line:PA-1	10807-111A6	56.88	6.82	4.96	3.72	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	37.20	7.24	3.94	3.05	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	35.93	35.55	2.65	2.27	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	57.04	6.43	2.40	2.94	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	40.71	6.84	2.28	0.65	1.63
testis, adult, pool1	10026-101D8	76.99	6.87	6.66	4.83	4.08
testis, adult, pool2	10096-102C6	71.27	12.63	6.32	6.32	6.77
thalamus - adult, donor10196	10168-103B6	67.34	12.14	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	59.86	5.00	0.78	0.31	3.91
thalamus, adult, donor10258, tech_rep1	10370-105G1	27.71	7.70	0.00	0.00	9.24
thalamus, adult, donor10258, tech_rep2	10370-105G1	29.15	1.32	0.16	0.33	2.14
thalamus, newborn, donor10223	10366-105F6	42.57	5.18	1.15	2.88	3.45
throat, adult	10209-103G2	42.19	2.50	1.50	0.75	2.25
throat, fetal, donor1	10061-101H7	41.44	3.35	3.66	0.30	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	38.36	10.53	8.55	4.77	0.60
thymus, adult, pool1	10027-101D9	77.54	6.26	4.57	2.49	2.39
thymus, fetal, pool1	10043-101F7	84.99	8.10	5.09	3.12	3.43
thyroid carcinoma cell line:KHM-5M	10776-110G2	45.74	4.39	3.32	2.66	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	65.10	3.49	2.93	1.54	0.70
thyroid, adult, pool1	10028-101E1	57.67	5.41	0.93	0.37	3.73
thyroid, fetal, donor1	10060-101H6	55.90	5.01	1.58	0.53	4.22
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	45.82	2.09	1.63	0.93	3.02
tongue, fetal, donor1	10059-101H5	49.66	1.18	0.79	0.00	3.94
tonsil, adult, pool1	10047-101G2	75.73	3.21	1.40	0.60	1.70
trachea, adult, pool1	10029-101E2	69.37	1.80	1.31	0.74	2.04
trachea, fetal, donor1	10058-101H4	52.32	3.46	2.31	0.77	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	46.41	1.06	4.61	2.83	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	83.08	10.33	4.26	6.99	1.42
transitional-cell carcinoma cell line:JMSU1	10492-107B6	60.79	6.74	3.13	1.88	0.63
tridermal teratoma cell line:HGRT	10694-109G1	32.34	0.00	5.71	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.46	3.72	1.44	1.27	0.59
umbilical cord, fetal, donor1	10057-101H3	39.64	8.35	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	75.76	2.73	1.54	0.17	3.07
uterus, fetal, donor1	10055-101H1	45.05	2.56	3.58	1.02	1.02
vagina, adult	10204-103F6	25.85	1.94	0.65	0.00	0.65
vein, adult	10191-103E2	35.29	0.44	1.32	0.22	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	47.00	4.27	2.67	0.53	0.53